4GG5 | Crystal structure of CMET in complex with novel inhibitor | date | 2012-08-05 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | Liu, Q.F., Chen, T.T., Xu, Y.C. | ||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.42 | ||||||||||||
ligand | 0J3 BindingDB | enzyme |
| ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Multisubstituted quinoxalines and pyrido[2,3-d]pyrimidines: Synthesis and SAR study as tyrosine kinase c-Met inhibitors., Wu K, Ai J, Liu Q, Chen T, Zhao A, Peng X, Wang Y, Ji Y, Yao Q, Xu Y, Geng M, Zhang A, Bioorg Med Chem Lett. 2012 Oct 15;22(20):6368-72. doi:, 10.1016/j.bmcl.2012.08.075. Epub 2012 Aug 27. PMID:22985853 |
Data retrieval |
View 4GG5 in 3D |
Visual 3D analysis of 4GG5 |
Structure-derived information |
Sequence-derived information |
Other resources with information on 4GG5 |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |